| P2093 | author name string | Ronnie Fass | |
| | Henry P. Parkman | |
| | Amy E. Foxx-Orenstein | |
| P2860 | cites work | Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force | Q28189254 |
| | Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? | Q30372083 |
| | Nutrition concerns for the patient with gastroparesis | Q30444574 |
| | The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. | Q30467463 |
| | Relationships of upper gastrointestinal motor and sensory function with glycemic control | Q32050159 |
| | Different faces of gastroparesis | Q33555343 |
| | Gastrointestinal involvement in patients with diabetes mellitus: Part I (first of two parts). Epidemiology, pathophysiology, clinical findings | Q33752115 |
| | Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes | Q33782095 |
| | Autoimmune gastrointestinal dysmotility treated successfully with pyridostigmine | Q34581268 |
| | Gastroparesis: current diagnostic challenges and management considerations | Q34602527 |
| | A systematic review of surgical therapy for gastroparesis | Q35565623 |
| | Treatment of diabetic gastroparesis by high-frequency gastric electrical stimulation | Q35757449 |
| | American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis | Q35936586 |
| | Tricyclic antidepressants for chronic vomiting in diabetic patients | Q36695351 |
| | Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Q37009041 |
| | Therapy Insight: gastrointestinal complications of diabetes--pathophysiology and management | Q37082463 |
| | How good is cola for dissolution of gastric phytobezoars? | Q37192665 |
| | Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy | Q37196851 |
| | Diabetes mellitus and gastric emptying: questions and issues in clinical practice | Q37554194 |
| | Factors contributing to hospitalization for gastroparesis exacerbations | Q37598598 |
| | Erythromycin in the Treatment of Diabetic Gastroparesis. | Q41009371 |
| | Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review | Q41150653 |
| | Coeliac plexus block in the management of chronic abdominal pain due to severe diabetic gastroparesis | Q42282245 |
| | Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? | Q43212213 |
| | Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies | Q43226831 |
| | Predictors of delayed gastric emptying in diabetes | Q43651899 |
| | Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying | Q43923612 |
| | A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis | Q44860382 |
| | Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia | Q46284007 |
| | A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis | Q46415846 |
| | Upper abdominal symptoms in patients with Type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy | Q46620373 |
| | Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis | Q50147994 |
| | Electrical stimulation for gastroparesis. Gastric motility restored. | Q51302609 |
| | Development and content validity of a gastroparesis cardinal symptom index daily diary. | Q51867040 |
| | Esophageal dysfunction in diabetes mellitus: is there a relation to clinical manifestation of neuropathy? | Q67592817 |
| | Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis | Q69264652 |
| | Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus | Q69665480 |
| | Relationship of a satisfactory outcome to normalization of delayed gastric emptying after Nissen fundoplication | Q69771495 |
| | Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus | Q70245065 |
| | Jejunostomy feeding in the management of gastroparesis diabeticorum | Q70283721 |
| | Prevalence and determinants of solid and liquid gastric emptying in unstable type I diabetes. Relationship to postprandial blood glucose concentrations | Q73112478 |
| | Gastric electrical stimulation for medically refractory gastroparesis | Q73735575 |
| | Assessment of gastric emptying using a low fat meal: establishment of international control values | Q73999675 |
| | Relationship between esophageal dysfunction and neuropathy in diabetic patients | Q74248560 |
| | A new endoscopic technique for the removal of gastric phytobezoars | Q74253574 |
| | Natural history of diabetic gastroparesis | Q74655532 |
| | An appraisal of a new antiemetic drug: prochlorperazine | Q74744338 |
| | Gastroparesis Cardinal Symptom Index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms | Q80057913 |
| | American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis | Q80947657 |
| | Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis | Q81458634 |
| | Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects | Q81528828 |
| | Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis | Q81810853 |
| | Pharmacotherapy of gastroparesis | Q83292719 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-16 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Gastroenterology & hepatology | Q26842161 |
| P1476 | title | Treatment of patients with diabetic gastroparesis | |
| P478 | volume | 6 | |